HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Cash from Financing Activities
HUTCHMED (China) Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Financing Activities
$48.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Cash from Financing Activities
HK$195.5m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
5%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Financing Activities
-¥5.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-30%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Financing Activities
-¥882.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Financing Activities
-HK$6.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Cash from Financing Activities?
Cash from Financing Activities
48.7m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Cash from Financing Activities amounts to 48.7m USD.
What is HUTCHMED (China) Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
14%
The average annual Cash from Financing Activities growth rates for HUTCHMED (China) Ltd have been -45% over the past three years , and 14% over the past ten years .